Jubilant Life Sciences is currently trading at Rs. 836.00, up by 31.00 points or 3.85% from its previous closing of Rs. 805.00 on the BSE.
The scrip opened at Rs. 806.20 and has touched a high and low of Rs. 837.00 and Rs. 806.20 respectively. So far 33,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1039.00 on 08-Feb-2018 and a 52 week low of Rs. 600.00 on 25-Oct-2017.
Last one week high and low of the scrip stood at Rs. 846.95 and Rs. 736.85 respectively. The current market cap of the company is Rs. 13,483.00 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 29.04% and 20.28% respectively.
Jubilant Life Sciences has issued Commercial Papers (CPs) worth Rs 75 crore on April 23, 2018. The company has issued two Papers, one worth Rs 50 crore and other worth Rs 25 crore.
The tenure of instrument is 29 days for Paper worth Rs 50 crore and will mature on May 22, 2018, while the tenure of instrument is 38 days for Paper worth Rs 25 crore and will mature on May 31, 2018.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
